{"title":"已发表的人类临床试验:COVID-19疫苗的文献综述","authors":"Sarah El-Nakeep","doi":"10.30654/mjia.10011","DOIUrl":null,"url":null,"abstract":"Emergency situations as COVID-19 pandemic require emergency authorizations; these are intended to shorten the time for each of the phases of the clinical trials or as termed by Pfizer ‘Project Lightspeed’ [1]. The aim is to have an effective vaccine that could offer protection to the population and end the pandemic in the most urgent and efficient way possible, as time elapsed equals the loss of more lives.","PeriodicalId":413658,"journal":{"name":"Mathews Journal of Immunology & Allergy","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Literature Review of the Published Human Clinical Trials: On COVID-19 Vaccines\",\"authors\":\"Sarah El-Nakeep\",\"doi\":\"10.30654/mjia.10011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Emergency situations as COVID-19 pandemic require emergency authorizations; these are intended to shorten the time for each of the phases of the clinical trials or as termed by Pfizer ‘Project Lightspeed’ [1]. The aim is to have an effective vaccine that could offer protection to the population and end the pandemic in the most urgent and efficient way possible, as time elapsed equals the loss of more lives.\",\"PeriodicalId\":413658,\"journal\":{\"name\":\"Mathews Journal of Immunology & Allergy\",\"volume\":\"21 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mathews Journal of Immunology & Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30654/mjia.10011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mathews Journal of Immunology & Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30654/mjia.10011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Literature Review of the Published Human Clinical Trials: On COVID-19 Vaccines
Emergency situations as COVID-19 pandemic require emergency authorizations; these are intended to shorten the time for each of the phases of the clinical trials or as termed by Pfizer ‘Project Lightspeed’ [1]. The aim is to have an effective vaccine that could offer protection to the population and end the pandemic in the most urgent and efficient way possible, as time elapsed equals the loss of more lives.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
